We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Arcutis Biotherapeutics
ARQT
$3.56B
| $1.48M | ﹤0.01% |
148,874
| – | – |
|
802
Takeda Pharmaceutical
TAK
$54.8B
| $1.46M | ﹤0.01% |
105,073
| – | – |
|
803
Perrigo
PRGO
$1.48B
| $1.42M | ﹤0.01% |
44,174
| – | – |
|
804
Jabil
JBL
$31.5B
| $1.39M | ﹤0.01% |
10,343
-802
| -7% | -$108K |
|
805
Xenon Pharmaceuticals
XENE
$6.6B
| $1.38M | ﹤0.01% |
32,036
| – | – |
|
|
JKS
806
JinkoSolar
JKS
$864M
| $1.35M | ﹤0.01% |
53,602
+31,009
| +137% | +$852K |
|
807
Dentsply Sirona
XRAY
$2.81B
| $1.34M | ﹤0.01% |
40,512
-70,982
| -64% | -$2.43M |
|
808
GlobalFoundries
GFS
$31.5B
| $1.33M | ﹤0.01% |
25,453
-551
| -2% | -$30.2K |
|
809
Ralph Lauren
RL
$22.6B
| $1.32M | ﹤0.01% |
7,030
-243
| -3% | -$40.2K |
|
810
Mohawk Industries
MHK
$6.8B
| $1.31M | ﹤0.01% |
10,017
-187
| -2% | -$21K |
|
811
Liberty Global Class C
LBTYK
$3.41B
| $1.28M | ﹤0.01% |
72,759
-8,714
| -11% | -$168K |
|
812
Performance Food Group
PFGC
$17.6B
| $1.28M | ﹤0.01% |
17,161
-723
| -4% | -$53.2K |
|
813
GDS Holdings
GDS
$6.24B
| $1.28M | ﹤0.01% |
192,600
-408
| -0.2% | -$2.76K |
|
814
First Industrial Realty Trust
FR
$9.13B
| $1.27M | ﹤0.01% |
24,135
-1,210
| -5% | -$63.9K |
|
815
News Corp Class B
NWS
$17.6B
| $1.25M | ﹤0.01% |
46,174
-1,104
| -2% | -$29.2K |
|
|
WCN
816
Waste Connections
WCN
$43.7B
| $1.25M | ﹤0.01% |
7,247
-595
| -8% | -$95.6K |
|
817
EQT Corp
EQT
$31B
| $1.22M | ﹤0.01% |
32,900
-2,466
| -7% | -$88.3K |
|
|
SAGE
818
DELISTED
Sage Therapeutics
SAGE
| $1.21M | ﹤0.01% |
64,801
| – | – |
|
819
Ryman Hospitality Properties
RHP
$7.99B
| $1.18M | ﹤0.01% |
10,190
-507
| -5% | -$58.2K |
|
820
National Health Investors
NHI
$3.86B
| $1.14M | ﹤0.01% |
18,076
+408
| +2% | +$23K |
|
821
Tapestry
TPR
$28.6B
| $1.12M | ﹤0.01% |
23,566
+6,196
| +36% | +$266K |
|
822
JD.com
JD
$40B
| $1.08M | ﹤0.01% |
39,561
-13,983
| -26% | -$342K |
|
|
IGR
823
CBRE Global Real Estate Income Fund
IGR
$721M
| $1.04M | ﹤0.01% |
193,046
| – | – |
|
824
Kanzhun
BZ
$6.66B
| $1.03M | ﹤0.01% |
58,814
+758
| +1% | +$12K |
|
825
Canadian Solar
CSIQ
$1.02B
| $1.03M | ﹤0.01% |
52,147
+23,293
| +81% | +$502K |
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.